Exosome-based delivery of Wedelolactone shows promise for sepsis-induced liver injury
A novel exosome-based drug delivery system (Exo@WEL) enhances liver-targeting and hepatoprotection of Wedelolactone.
Therapeutic Area
Therapeutic area intelligence for Sepsis-induced liver injury with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.